FBIO – fortress biotech, inc. (US:NASDAQ)
Stock Stats
News
Fortress Biotech (NASDAQ:FBIO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission [Yahoo! Finance]
Fortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA Resubmission
Fortress Biotech (NASDAQ:FBIO) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Fortress Biotech, Inc. For: Jan 13
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: Klein Dov
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: Lorenz Kevin
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: LOBELL J JAY
Form 4 Fortress Biotech, Inc. For: Jan 01 Filed by: Hoenlein Malcolm
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.